Approval · Notice of Compliance 16948 · 2015
NORLEVO: Notice of Compliance 16948
Issued May 28, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16948
- Date
- May 28, 2015
- Company
- Laboratoire Hra PharmaChâtillon, --, France
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes in specificationsd; new drug product manufacaturing site, changes in shelf life specification, change in the embossing of the finished product
- Therapeutic class
- Emergency contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORLEVO | Not yet assigned | — |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB